Literature DB >> 2186829

Thrombolysis and the general practitioner. 2. Useful after careful evaluation of patients.

R G Wilcox1.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2186829      PMCID： PMC1662582          DOI： 10.1136/bmj.300.6728.869

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

Authors:  R G Wilcox; G von der Lippe; C G Olsson; G Jensen; A M Skene; J R Hampton
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

2.  Bolus streptokinase after myocardial infarction.

Authors:  G H Hall
Journal:  Lancet       Date:  1987-07-11       Impact factor: 79.321

Review 3.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.

Authors:  M J Davies; A C Thomas
Journal:  Br Heart J       Date:  1985-04

4.  Sudden cardiac death. I. A decade's experience with out-of-hospital resuscitation.

Authors:  L A Cobb; J A Werner; G B Trobaugh
Journal:  Mod Concepts Cardiovasc Dis       Date:  1980-06

5.  The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.

Authors:  K A Reimer; J E Lowe; M M Rasmussen; R B Jennings
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

6.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

7.  Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase.

Authors:  G Koren; A T Weiss; Y Hasin; D Appelbaum; S Welber; Y Rozenman; C Lotan; M Mosseri; D Sapoznikov; M H Luria
Journal:  N Engl J Med       Date:  1985-11-28       Impact factor: 91.245

8.  Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.

Authors:  F Van de Werf; A E Arnold
Journal:  BMJ       Date:  1988-11-26

9.  Early reporting of myocardial infarction: impact of an experiment in patient education.

Authors:  J M Rowley; J D Hill; J R Hampton; J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-12
  9 in total
  4 in total

1.  Thrombolysis and the general practitioner.

Authors:  A C Pell; P C Stuart; M J Stewart; D M Fraser
Journal:  BMJ       Date:  1990-05-05

Review 2.  Criteria for drug usage review of thrombolytics in acute myocardial infarction.

Authors:  S McGlynn
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

3.  Delay in presentation after myocardial infarction.

Authors:  A G Heriot; S J Brecker; D J Coltart
Journal:  J R Soc Med       Date:  1993-11       Impact factor: 18.000

4.  Coronary care follow-up study: acute care required immediately following thrombolytic therapy.

Authors:  C Ellicott; D B Shaw; B J Kirby; T Bailey
Journal:  J R Soc Med       Date:  1993-06       Impact factor: 18.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.